The Asia-Pacific medical technology (MedTech) market is the largest in the world. A pandemic, rapidly-growing population and severe healthcare worker shortage have accelerated the sector’s development—and Singapore is at the forefront of this change. More than 60 multinational MedTech firms, including Abbott and Medtronics, and 300+ homegrown companies call Singapore home. Engaging in cutting-edge research & development of products like wearable health devices and AI-driven diagnostics technologies, these companies have contributed over $13 billion annually to the Singaporean economy. Singapore’s flourishing MedTech scene is made possible by generous funding, a robust start-up ecosystem, support from legacy institutions and numerous talents, while opportunities for growth abound due to the rise of chronic illnesses (especially diabetes, cardiovascular disease and hypertension), growing consumer interest in personal health and an urgent need to plug the manpower gap in the health sector. Medical technology is heavily innovation-dependent: extensive research is needed to uncover complex health conditions, creativity to ingeniously and adequately address these problems and constant experimentation to guarantee effectiveness. Without a constant flow of talent, expertise and novel ideas, solutions such as Web Biotech’s Spyder Personal wearable heart monitor and KroniKare’s AI-enabled wound scanning device would not be possible. The sector’s extreme reliance on human capital thus necessitates a consistent supply of scientists, medical researchers, entrepreneurs and deep-technology professionals—numbers that the local talent pool alone is too small to meet. To support the flow of local graduates and professionals, foreign talent is needed. Foreign companies and professionals bring with them expertise that can diversify R&D activity, introduce new perspectives and areas for growth and novel ideas to solve longstanding medical problems: the introduction of Irish health platform HealthBeacon significantly improved elderly patients’ adherence to their home medication regimens, addressing the issue of elderly patients’ self-neglect and reducing medical complications that would have exacted a toll on an already-strained Singaporean healthcare system. Foreign talent is thus necessary to further grow the local MedTech scene and inspire new solutions—all of which keep Singapore on the cutting edge of medical technology and research.

The Asia-Pacific medical technology (MedTech) market is the largest in the world. A pandemic, rapidly-growing population and severe healthcare worker shortage have accelerated the sector’s development—and Singapore is at the forefront of this change. More than 60 multinational MedTech firms, including Abbott and Medtronics, and 300+ homegrown companies call Singapore home. Engaging in cutting-edge research & development of products like wearable health devices and AI-driven diagnostics technologies, these companies have contributed over $13 billion annually to the Singaporean economy. Singapore’s flourishing MedTech scene is made possible by generous funding, a robust start-up ecosystem, support from legacy institutions and numerous talents, while opportunities for growth abound due to the rise of chronic illnesses (especially diabetes, cardiovascular disease and hypertension), growing consumer interest in personal health and an urgent need to plug the manpower gap in the health sector. Medical technology is heavily innovation-dependent: extensive research is needed to uncover complex health conditions, creativity to ingeniously and adequately address these problems and constant experimentation to guarantee effectiveness. Without a constant flow of talent, expertise and novel ideas, solutions such as Web Biotech’s Spyder Personal wearable heart monitor and KroniKare’s AI-enabled wound scanning device would not be possible. The sector’s extreme reliance on human capital thus necessitates a consistent supply of scientists, medical researchers, entrepreneurs and deep-technology professionals—numbers that the local talent pool alone is too small to meet. To support the flow of local graduates and professionals, foreign talent is needed. Foreign companies and professionals bring with them expertise that can diversify R&D activity, introduce new perspectives and areas for growth and novel ideas to solve longstanding medical problems: the introduction of Irish health platform HealthBeacon significantly improved elderly patients’ adherence to their home medication regimens, addressing the issue of elderly patients’ self-neglect and reducing medical complications that would have exacted a toll on an already-strained Singaporean healthcare system. Foreign talent is thus necessary to further grow the local MedTech scene and inspire new solutions—all of which keep Singapore on the cutting edge of medical technology and research. via Immigration SG LLP - IASG